Last year was a rough one for growth stocks, as investors shied away from risk in the face of rising interest rates. But in 2023, investors are once again on the hunt for companies with above-average growth rates. This is evidenced by the performance of the Vanguard Growth Index Fund (NYSEARCA:VUG) versus that of the
The alternative energy space has come under pressure recently amid concerns about a potential slowdown in demand in China. That may be true in the short-term. However, rising electric vehicle (EV) demand will create a long-term growth story, making these three lithium stocks to buy good choices to profit from the current correction. Specifically, Chinese
While focusing on equities with upside potential tends to be the superior long-term option due to the U.S. capital market’s upward bias, good investors can’t avoid the topic of stocks to sell. Invariably, in this investing game, you’re going to pick a few clunkers – we all do. What separates successful players from those who
While there are plenty of highly popular dividend stocks out there to choose from, sometimes the best opportunities are found where few others are looking. This is because less attention in the dividend investing community can result in greater inefficiency in pricing. This often yields compelling buying opportunities. Popular dividend stocks are often popular for
Editor’s note: “Buy the Dip in a Down Market for Big Returns” was previously published in February 2023. It has since been updated to include the most relevant information available. Feb. 21, 2023 was an awful day for stocks. And with the market down, investors get fearful. The S&P 500 fell 2%, marking one of
In this article NYCB WGRO TSLA AKAM MHK WW WHR KMX Follow your favorite stocksCREATE FREE ACCOUNT Pipettes are seen at the Moderna Therapeutics Inc. lab in Cambridge, Massachusetts, U.S., on Tuesday, Nov. 14, 2017. Moderna this week started testing Adam Glanzman | Bloomberg | Getty Images Check out the companies making headlines in midday
Artificial intelligence (AI) has been the talk of the town this year, and it seems like everyone is looking to get in on the action. The opportunity in AI is massive, with the market expected to be worth over $1.5 trillion by 2030. However, investors must sift the gems from the rubble and understand which
How much risk can you tolerate? If the answer is “a lot,” then I invite you to take a second look at online car retailer Carvana (NYSE:CVNA). Sure, the company has serious problems, but the CVNA stock price seems to already reflect Carvana’s financial issues. Besides, to Carvana’s credit, the company poses a threat to traditional,
Nvidia (NASDAQ:NVDA) stock stands to benefit immensely from the ongoing AI race. Shares are up 89% since the start of the year. And the momentum is not slowing. The semiconductor company makes innovative graphics processing units for various applications. Nvidia’s GPUs are particularly well-suited for AI as they can handle large amounts of data in
Just because we’re in a bear market, doesn’t mean you can’t score huge profits from buying stocks. You just have to find the right stocks to buy… Like one AI startup by the name of Symbotic (SYM). Most investors have never heard of this stock. On the popular finance commentary site Stocktwits, Symbotic stock has
Before you jump into a hasty trade with Silvergate Capital (NYSE:SI) stock, think carefully and consider the risks involved. Silvergate Capital is an unsuccessful bank that may be in its final stages of existence. Plus, it appears that regulators are cracking down on failing banks, and this doesn’t bode well for Silvergate Capital. Based in California,
Lithium has been among the hottest commodities as we transition to a post-pandemic world. The price for a metric ton of lithium (2205lb.) was worth ~$6,000 back in August 2020, which climbed well north of $93,000 at its peak in November 2021 if you adjust for currency changes. China’s lockdown did nothing to lower those
Biotech stock fortunes hinge upon potential, progress, and the ultimate realization of drugs and devices that treat diseases. Stringent regulatory processes and long development times result in substantial costs. Those costs are subsidized on the back end upon commercial success, often leading to extremely high sales. Investing in biotech stocks is often about identifying the next
Sorry to be the bearer of bad news, but Design Therapeutics (NASDAQ:DSGN) has good intentions and less-than-stellar financials. Design Therapeutics may be a pioneer in the field of genomic medicine, and that’s commendable. Yet, DSGN stock is still likely to lose value in 2023 and might even be delisted someday. Based in California, Design Therapeutics develops
Nvidia (NASDAQ:NVDA) stock is among the year’s strongest performers. The stock is up almost 132% during the last six months, an astounding return by all measures. The momentum in the artificial intelligence (AI) industry shows no signs of decelerating as the race to develop advanced technologies intensifies. As Nvidia works with most companies active in
In this article WHR NEM KMX UPST ARRY MRNA LC BMBL Follow your favorite stocksCREATE FREE ACCOUNT Bloomberg | Getty Images Check out the companies making headlines before the bell Tuesday. CarMax — Shares of the vehicle retailer soared 7% on the back of better-than-expected quarterly earnings. CarMax earned 44 cents per share, beating a
As an investor, it is essential to have a diverse range of stocks within a portfolio. Penny stocks may not make up most of someone’s holdings, but they are a crucial investment addition. They are prone to massive volatility swings from news events, downgrades and upgrades, product approval, and earnings. But penny stocks with solid
As the market starts its recovery, investors may be looking for dividend stocks to sell to lighten their portfolio. Dividend payments from stock holdings can be an important source of income for investors. However, particularly high yielding dividends can also be a sign of financial stress or trouble at a company. Often, companies that are
This year, stock markets have experienced growth, although not uniformly. Some stocks are recovering, while others are still declining or stagnating. However, unexpectedly many overvalued blue-chip stocks that have consistently outperformed the market in the past decade are now underperforming. These are well-known companies that people encounter in their everyday lives. Because of various internal
Shares in China-based electric vehicle maker Nio (NYSE:NIO) appeared to be on the verge of a rebound in late March, but this month, NIO stock has fallen back into a slump. Not exactly surprising, considering that the company once again has reported underwhelming vehicle delivery numbers. Some investors continue to believe in the bull case